The combination of DKK3 and ITIH5 (either gene methylated) substantially improved sensitivity and specificity, which predicts breast cancer with a sensitivity of 41% and a specificity of 93%, 100%, and 88% in age-matched healthy control samples, benign breast disease, and colon cancer samples, respectively. Here, ITIH5 is linked to breast fibrocystic disease.